|
2022
|
Invention
|
Compositions for and methods of treatment with mutant a1 adenosine receptor plasmid cdnas.
Novel... |
|
2011
|
Invention
|
Methods of use and kit for measurement of lipopolysaccharide with a time resolved fluorescence ba... |
|
|
Invention
|
Methods and pharmaceutical compositions for preventing and treating renal impairment. 1 adenosine... |
|
|
Invention
|
Methods and pharmaceutical compositions for preventing and treating renal impairment. The present... |
|
2008
|
Invention
|
A1 adenosine receptor antagonists. This invention relates to compounds of formula (I), Wherein R1... |
|
|
Invention
|
A1 adenosine receptor antagonists.
This invention relates to compounds of formula... |
|
|
Invention
|
A1 adenosine receptor antagonists.
Compounds of the general formula (I) are described:
Compoun... |
|
|
Invention
|
Methods for preventing and treating tissue injury and sepsis associated with yersinia pestis infe... |
|
2007
|
Invention
|
Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer. ... |
|
|
Invention
|
1 adenosine receptor antagonists. 1-8 straight or branched alkylene or alkenylene.
1... |
|
|
Invention
|
A1 adenosine receptor antagonists. Compounds of the general formula (I) are described:
wherein ... |
|
|
Invention
|
Compositions and methods for treating respiratory disorders.
Methods and compositions for treati... |
|
|
Invention
|
Compositions and methods for treating respiratory disorders. Methods and compositions for treatin... |
|
2006
|
Invention
|
Methods and pharmaceutical compositions for treating sepsis. Methods and compositions for treatin... |
|
2004
|
Invention
|
Methods and compositions for producing antigenic responses. 1 adenosine receptor activating agent... |
|
|
Invention
|
Methods and compositions for producing antigenic responses. The present invention relates to meth... |
|
|
Invention
|
Methods and compositions for producing antigenic responses.
The present invention rela... |
|
|
Invention
|
A1 adenosine receptor antagonists.
This invention relates to compounds of formula (I): wherein R... |
|
|
Invention
|
A1 adenosine receptor antagonists. This invention relates to compounds of formula (I): wherein R1... |
|
|
Invention
|
A1 adenosine receptor antagonists.
This invention relates to compounds of formula (I):... |
|
|
Invention
|
A1 adenosine receptor antagonists. 1 adenosine receptor antagonist compositions of formula (I) fi... |
|
|
Invention
|
A1 adenosine receptor antogonists. R3 is Alk14ArR16, wherein Alk14 is C1-8 straight or branched a... |
|
|
Invention
|
A1 adenosine receptor antogonists.
R3 is Alk14ArR16, wherein Alk14 is C1-8 straight or... |
|
|
Invention
|
1 adenosine receptor antagonists. Compounds of the general formula (I) are described:
wherein A... |
|
|
Invention
|
A1 adenosine receptor antagonists. Compounds of the general formula (I) are described wherein A i... |
|
|
Invention
|
A1 adenosine receptor antagonists.
Compounds of the general formula (I) are described ... |
|
2003
|
Invention
|
Methods and formulations of using a1 adenosine receptor antagonists and p2x purinoceptor antagoni... |
|
|
Invention
|
Methods and formulations for increasing the affinity of a1 adenosine receptor ligands for the a1 ... |
|
|
Invention
|
Combination treatments for purinoceptor-related disorders. The present invention provides methods... |
|
2002
|
Invention
|
Methods and formulations of using a1 adenosine and p2x purinoreceptor antagonists. A1 adenosine r... |
|
|
Invention
|
Methods and formulations of using a1 adenosine and p2x purinoreceptor antagonists.
A1 ... |
|
2000
|
Invention
|
Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer a... |
|
|
Invention
|
A1 adenosine receptor antagonists. A compound useful as an A1 adenosine receptor antagonist has t... |
|
1999
|
Invention
|
Methods of inhibiting tumor growth using adenosine receptor activated cells. Methods of treating ... |
|
|
Invention
|
Methods for the prevention and treatment of fibrosis and sclerosis.
Methods of treatin... |
|
1998
|
Invention
|
Methods for the prevention and treatment of fibrosis and sclerosis. Methods of treating or preven... |
|
|
Invention
|
A1 adenosine receptor antagonists. R.sub.4 is of the formula: ##STR3## wherein R.sub.8 is select... |
|
1997
|
Invention
|
A1 adenosine receptor antagonists.
A compound useful as an A1 adenosine receptor ... |
|
|
Invention
|
Methods and compositions for treating and diagnosing tumors using adenosine receptor activated ce... |
|
1996
|
Invention
|
A1 adenosine receptor antagonists. R.sub.4 is of the formula: ##STR3## wherein R.sub.8 is selecte... |
|
|
Invention
|
Method and compositions for treating and diagnosing tumors using adenosine receptor activated cel... |
